New drug helps control bleeding in babies with hemophilia

NCT ID NCT05248594

First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 25 times

Summary

This study looked at how well the drug emicizumab works in infants and children up to 3 years old with hemophilia A, a bleeding disorder. Researchers tracked how many children had breakthrough bleeding while on the drug and whether they needed extra clotting factor. The goal was to see how the drug performs in everyday medical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Hospital at Montefiore

    The Bronx, New York, 10467, United States

  • Comprehensive Center for Hemophilia and Coagulation Disorders (Cornell)

    New York, New York, 10065, United States

  • Connecticut Children's Hemophilia Treatment Center - Connecticut Children's Medical Center

    Hartford, Connecticut, 06106, United States

  • Dartmouth Hitchcock Hemophilia Center - Mary Hitchcock Memorial Hospital

    Lebanon, New Hampshire, 03766, United States

  • Mary M Gooley Hemophilia Center, Inc.

    Rochester, New York, 14621, United States

  • Newark Beth Israel

    Newark, New Jersey, 07112, United States

  • Northwell Health Hemostasis and Thrombosis Center

    Staten Island, New York, 11030, United States

  • SUNY Upstate Hemophilia Treatment Center - HTC 058

    Syracuse, New York, 13210, United States

  • Western NY Blood Care - Research Foundation for SUNY

    Buffalo, New York, 14202, United States

  • Yale Hemophilia Treatment Center

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.